Results 21 to 30 of about 211,411 (286)

Identifying chemokines as therapeutic targets in renal disease: Lessons from antagonist studies and knockout mice [PDF]

, 2004
Chemokines, in concert with cytokines and adhesion molecules, play multiple roles in local and systemic immune responses. In the kidney, the temporal and spatial expression of chemokines correlates with local renal damage and accumulation of chemokine ...
Abdi R, Anders HJ, Anders HJ, Anders HJ, Bruhl H, Burne-Taney MJ, Feng L, Fituri O, Fujinaka H, Garcia GE, Grone HJ, Keane MP, Mack M, Miura M, Murphy PM, Nath KA, Perez de Lema G, Rollins BJ, Romagnani P, Segerer S, Segerer S, Segerer S, Tang WW, Taub DD, Tesch GH, Tokuda A, Topham PS, Vielhauer V, Vielhauer V, Wada T, Wang Y, Wenzel U, Wu X, Wu X, Zernecke A   +34 more
core   +1 more source

Changes in Proteinuria on the Risk of All-Cause Mortality in People with Diabetes or Prediabetes: A Prospective Cohort Study

Journal of Diabetes Research, 2017
Background. Proteinuria has been related to all-cause mortality, showing regression or progression. However, few studies have focused on the relationship between proteinuria changes and all-cause mortality.
Yang Sun, Anxin Wang, Xiaoxue Liu, Zhaoping Su, Junjuan Li, Yanxia Luo, Shuohua Chen, Jianli Wang, Xia Li, Zhan Zhao, Huiping Zhu, Shouling Wu, Xiuhua Guo   +12 more
doaj   +1 more source

Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome

Nefrología (English Edition), 2021
Introduccion: In nephrotic syndrome, increased podocyturia accompanies pathologic proteinuria. The therapeutic regimen with enalapril, losartan and amiloride could reduce both variables.
Miguel Liern, Anabella Colazo, Graciela Vallejo, Elsa Zotta   +3 more
doaj   +1 more source

Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria

Renal Failure, 2018
Background: Heavy proteinuria in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (GN) is usually considered to be associated with immune deposits in renal biopsy.
Peng-Cheng Xu, Tong Chen, Shan Gao, Shui-Yi Hu, Li Wei, Tie-Kun Yan   +5 more
doaj   +1 more source

Nonalbumin Proteinuria in Islet Transplant Recipients

Cell Transplantation, 2010
The aim of this study was to evaluate the importance of nonalbumin-predominant proteinuria on kidney function (KF) after islet transplantation (ITx). Twenty-four-hour proteinuria and albuminuria were available in 27 recipients.
Cristiane B. Leitão, Tatiana Froud, Pablo Cure, Thipaporn Tharavanij, Antonello Pileggi, Camillo Ricordi, Rodolfo Alejandro   +6 more
doaj   +1 more source

Relação proteína/creatinina na urina versus proteinúria de 24 horas na avaliação de nefrite lúpica

Brazilian Journal of Nephrology, 2012
INTRODUÇÃO: Tem-se defendido a utilização do índice urinário proteína e creatinina em substituição à determinação de proteinúria de 24 horas para acompanhamento de doenças glomerulares, considerando-se as vantagens de maior facilidade na coleta e o menor
Grace Tamara Moscoso Solorzano, Marcus Vinicius Madureira e Silva, Sílvia Regina Moreira, Sonia Kiyomi Nishida, Gianna Mastroianni Kirsztajn   +4 more
doaj   +1 more source

The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria. [PDF]

PLoS ONE, 2012
Post-transplant proteinuria is a common complication after renal transplantation; it is associated with reduced graft and recipient survival. However, the prevalence of histological causes has been reported with considerable variation.
Qiquan Sun, Song Jiang, Xue Li, Xianghua Huang, Kenan Xie, Dongrui Cheng, Jinsong Chen, Shuming Ji, Jiqiu Wen, Mingchao Zhang, Caihong Zeng, Zhihong Liu   +11 more
doaj   +1 more source

Association between proteinuria and incident colorectal cancer: analysis of a nationwide population-based database

BMJ Open, 2022
Objectives This study aimed to assess whether adults with proteinuria were at a higher risk of incident colorectal cancer (CRC) than those without proteinuria using a large-scale population-based database.Design A retrospective observational study ...
Hideo Yasunaga, Yuichiro Yano, Hiroyuki Morita, Masaomi Nangaku, Toshimasa Yamauchi, Taisuke Jo, Issei Komuro, Takashi Yokoo, Hidehiro Kaneko, Hidetaka Itoh, Kojiro Morita, Katsuhito Fujiu, Norifumi Takeda, Nobuaki Michihata, Satoko Yamaguchi, Koichi Node, Akira Okada, Akira Nishiyama, Satoshi Matsuoka, Akira Fukui, Sunao Nakamura   +20 more
doaj   +1 more source

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer. Efficacy in combination with hormonal therapy [PDF]

, 2012
Background: Data on efficacy of bevacizumab (B) beyond first-line taxane -including regimen (BT) as first-line treatment are lacking. Although preclinical results that anti-angiogenic agents combined with hormonal therapy (HT) could be active, no ...
Cognetti F., D'Auria G., De Vita F., Fabi A., Ferretti G., Giannarelli D., Metro G., Nistico C., Papaldo P., Russillo M., Vidiri A.   +10 more
core   +3 more sources

Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus [PDF]

, 2015
Introduction ES-62, a phosphorylcholine (PC)-containing immunomodulator secreted by the parasitic worm Acanthocheilonema viteae, protects against nephritis in the MRL/Lpr mouse model of systemic lupus erythematosus (SLE).
Harnett, M. M., Harnett, W., Pineda, M. A., Rodgers, D. T., Suckling, C. J.   +4 more
core   +1 more source